Serum vitamin D levels per categorisation). by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Age. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Distribution. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Liquid Crystalline Features in a Polyolefin of Poly(methylene-1,3-cyclopentane) by Naofumi Naga (2084077)

“…A liquid crystalline phase has been discovered in a polyolefin of poly(methylene-1,3-cyclopentane) (PMCP) having low molecular weight, which was obtained with cyclization polymerization of 1,5-hexadiene (HD) using a zirconocene catalyst in the presence of chain transfer reagents. …”

Baseline maternal and infant demographics and clinical characteristics. by Ashenafi Shumey Cherkos (19434556)

Factors associated with growth at ~14 and 24-month age–longitudinal. by Ashenafi Shumey Cherkos (19434556)

Spring UTCI effect. by Wael Ghada (11719000)

Winter UTCI effect. by Wael Ghada (11719000)

Summer UTCI effect. by Wael Ghada (11719000)

Fall UTCI effect. by Wael Ghada (11719000)

Schematic representation of FixbbGCNs, the networks used in our experiments. by Jack B. Maguire (5123183)

Y743A disrupts internalization into lysosomes. by Joshua H. K. Tam (836784)

Reducing MALAT1 expression decreased fibrosis of NIH-3T3 and decreased the expression level of P2ry2. by Mengjie Chen (483583)

Ethanol exposed flight digitization. by Ishriak Ahmed (14265562)

Decreased CD1d expression by tumor correlates with decreased iNKT-mediated antitumor immunity <i>in vivo</i>. by Laura M. Hix (217695)

A hypothesis for the pregnancy disorders caused by a HFD, obesity, and/or diabetes. by Hui Zhao (7395)

a and b Illustrative representation of HbA1c trajectories. by Yuan Wang (14955)

Baseline characteristics. by Si-Jing Chen (15350263)

“…In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference −1.0 [−1.6 to −0.5]; Cohen’s <i>d</i> = 0.53; <i>p</i> < 0.001) and insomnia symptoms (−2.0 [−2.7 to −1.3], <i>d</i> = 0.78; <i>p</i> < 0.001) than the controls at post-intervention and throughout 6-month follow-up. …”

Secondary outcome results. by Si-Jing Chen (15350263)

“…In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference −1.0 [−1.6 to −0.5]; Cohen’s <i>d</i> = 0.53; <i>p</i> < 0.001) and insomnia symptoms (−2.0 [−2.7 to −1.3], <i>d</i> = 0.78; <i>p</i> < 0.001) than the controls at post-intervention and throughout 6-month follow-up. …”

Examples of histological slides after toluidine blue staining. by Florent Barry (14526499)